EcoDrugPlus

Somatostatin Receptor 5

Ensembl ID : ENSSPAG00000003668
Gene Symbol: SSTR5
1 Cross references
188 Possible Orthologues:

Somatostatin Receptor Type 5-Like

Ensembl ID : ENSSPAG00000005056
Gene Symbol: LOC103356709
2 Cross references
183 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSSPAG00000022217
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSSPAG00000007147
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSSPAG00000004040
Gene Symbol: LOC103367215
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSSPAG00000008065
Gene Symbol: SRD5A2
3 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSSPAG00000017749
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Substance-K Receptor-Like

Ensembl ID : ENSSPAG00000014701
Gene Symbol: LOC103373147
3 Cross references
199 Possible Orthologues:

Substance-P Receptor-Like

Ensembl ID : ENSSPAG00000002468
Gene Symbol: LOC103372244
3 Cross references
193 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSSPAG00000022811
Gene Symbol: TACR1
3 Cross references
163 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSSPAG00000008980
Gene Symbol: TACR1
4 Cross references
183 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSSPAG00000013525
Gene Symbol: TACR3
4 Cross references
208 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).